Recent Articles

April 17, 2017 10:40 am
Ralf Huss, M.D., Chief Medical Officer, Definiens
While it’s true that artificial intelligence and computer-based algorithms are making their way into both the lab and clinical practice, the adoption of these new technologies will not replace the work of the researchers themselves. On the contrary: it’ll enable them to become more effective than ever before.
April 13, 2017 10:34 am
Fabian V. Filipp, University of California, Merced
A field called epigenomics looks at chemical modifications that do not change our DNA sequence but can affect gene activity. What are the limitations, and can biomedicine use this to our advantage?
April 12, 2017 9:41 am
Bevin Fletcher
Paris-based Nanobiotix is a late clinical-stage nanomedicine company that is spearheading efforts to harness physics rather than biology, as a way to destroy cancer cells.
April 10, 2017 9:50 am
Dr. Antonio Felici, Director & Head of Microbiology, Drug Design and Discovery, Aptuit
If left unchecked, it’s thought that by 2050 the global number of deaths from antimicrobial resistance may be as high as 10 million per year - costing $100 trillion US dollars annually just to manage the effects. In this article, we look at the scale of the challenge, and consider the ways in which all international stakeholders need to work together in order to avoid these statistics becoming reality.
April 3, 2017 10:07 am
Thermo Fisher Scientific
Cell-based assays are used to facilitate the analysis of complex cellular functions and understand their impact on disease onset and development, as well as to enable pathway-specific drug screening.
March 20, 2017 10:24 am
Jeannie T. Lee and Wilhelm Haas, Massachusetts General Hospital and Harvard Medical School, Rosa Viner, Thermo Fisher Scientific.
To truly harness the power of quantitative proteomics in order to understand complex biological phenomena, researchers require accurate and high-throughput methods capable of comprehensively quantifying the large numbers of proteins present in biological samples.
March 17, 2017 11:00 am
Craig Morgan, Head of Marketing, goBalto
There is intense pressure to speed clinical trials and restrain costs. Given the burden of this duality, clinical project managers are expected to make smarter decisions on intelligence derived from clinical trial data. However, like the data they display, analytical dashboards alone do not provide value; it's up to experienced clinicians to distill insights.
March 16, 2017 10:19 am
Bevin Fletcher
Ten years in the making, researchers have finally received funding to build a prototype of the world’s first total body positron emission tomography (PET) scanner. The development could potentially significantly alter medical imaging and help advance a number of areas of biomedical research, including oncology, drug development and maternal-fetal studies, according to scientists involved in building the device.
March 13, 2017 10:11 am
Andy Tay, University of California Los Angeles, The Conversation
Every moment of life on our planet has had the force of gravity in the background. But the prospect of long-distance space travel means it's time to figure out what happens to our biology in its absence.
February 27, 2017 10:00 am
Nicole Ehrhart, Colorado State University, The Conversation
Dogs are great companions, and they also are proving to be great research subjects for cancer. Here's how our canine friends are pointing to possible treatments in human cancer.
Subscribe to Bioscience Technology